DKK1 and cancer: Dickkopf-1 (DKK1) is a well-characterized Wnt inhibitor and component of the Wnt/β-catenin signaling pathway, and its dysregulation is associated with multiple abnormal pathologies, including osteoporosis, Alzheimer’s disease, diabetes, and various cancers.